An Evaluation of the Effect of the AmnioFix Amniotic Membrane Allograft in Patients Undergoing Posterior Instrumentation Removal
Completed · Not applicable
Conditions studied: Adhesions of Soft Tissue
In brief
The objective of this study is to evaluate the clinical effectiveness of AmnioFix™ in the reduction of the tenacity and frequency of soft tissue adhesions during the removal of segmental posterior lumbar instrumentation.
Key facts
- Study ID
- NCT01357187
- Run by
- MiMedx Group, Inc.
- People needed
- 5
- Starts
- 2011-09-01
- Expected to finish
- 2014-05-01
- Last updated by the study team
- 2015-03-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults (18 years or older)
- Diagnosed with lumbar pathology requiring elective lumbar interbody fusion
- Willingness to comply to follow-up examinations and diagnostic imaging procedures
- Ability to give full written informed consent
You may not qualify if…
- Previous surgical procedure performed at same site
- Sign or symptoms of other disease which could result in allograft failure
- Require a corpectomy
- Participating in another drug or device clinical trial
- Pregnant or may become pregnant during the study
- Prisoner
- Involved in workmen's compensation or other litigation relative to a spine injury
- Past medical history of allograft implantation which resulted in graft failure
- Any condition requiring treatment above the normal standard of care
- Currently taking medications which could affect graft incorporation (supervising physicians discretion)
- Auto-Immune disease
- Renal failure
- Failure to sign or understand informed consent information
- History of drug and/or alcohol abuse
- Allergic to aminoglycosides
Where it is running
- Virginia Spine Institute — Reston, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.